Get the Stockscreener App
4.59
0.88%
0.04
Pre-market:
4.59
Lantern Pharma Inc stock is traded at $4.59, with a volume of 127.87K.
It is up +0.88% in the last 24 hours and up +13.05% over the past month.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
See More
Previous Close:
$4.55
Open:
$4.67
24h Volume:
127.87K
Relative Volume:
0.57
Market Cap:
$49.57M
Revenue:
-
Net Income/Loss:
$-19.25M
P/E Ratio:
-2.5787
EPS:
-1.78
Net Cash Flow:
$-17.87M
1W Performance:
+11.41%
1M Performance:
+13.05%
6M Performance:
+77.91%
1Y Performance:
+24.39%
1-Day Range:
$4.41
$4.7034
1-Week Range:
$3.8907
$4.7034
52-Week Range:
$2.55
$6.118
Lantern Pharma Inc Stock (LTRN) Company Profile
Name
Lantern Pharma Inc
Sector
Industry
Phone
972-277-1136
Address
1920 MCKINNEY AVENUE, DALLAS, TX
Compare LTRN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
4.59 | 49.14M | 0 | -19.25M | -17.87M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-21 | Initiated | H.C. Wainwright | Buy |
Lantern Pharma Inc Stock (LTRN) Latest News
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Marco Eagle
Why Lantern Pharma Inc. is moving todayProfit Target & Technical Pattern Based Signals - newser.com
Using flow based indicators on Lantern Pharma Inc.July 2025 Summary & Real-Time Volume Triggers - newser.com
Is Lantern Pharma Inc. stock a buy for dividend growthJuly 2025 Movers & Real-Time Volume Analysis - newser.com
What’s the recovery path for long term holders of Lantern Pharma Inc.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Lantern Pharma Inc. stock prediction for this weekEarnings Trend Report & Daily Profit Maximizing Tips - newser.com
Is Lantern Pharma Inc. showing signs of accumulation2025 Market Outlook & Verified Short-Term Trading Plans - newser.com
Lantern Pharma Inc.’s volatility index tracking explainedJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
What analysts say about Lantern Pharma Inc stockBullish Engulfing Patterns & Backtest Your Strategy Before You Risk Money - earlytimes.in
Is Lantern Pharma Inc a good long term investmentDividend Aristocrats List & Affordable Portfolio Building - earlytimes.in
FDA Guidance Advances Lantern Pharma's Pediatric Brain Cancer Therapy Toward 2026 Clinical Trial - citybuzz
Two stocks to invest in the future of pharma | 2025-09-29 | Investing News - Stockhouse
What drives Lantern Pharma Inc stock priceEconomic Indicators Overview & Small Budget Capital Investment - earlytimes.in
Lantern Pharma Holds Annual Stockholders Meeting - TipRanks
Lantern Pharma shareholders elect directors and approve stock option repricing - Investing.com
Lantern Pharma Inc Stock (LTRN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
4.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):